Jagsonpal Pharmaceuticals Ltd Board of Directors
₹ 1.6 Cr
Volume Transacted
(Nov 22, 2024)
25.6 K
Stocks Traded
(Nov 22, 2024)
Last Updated on: Nov 23, 2024
NSE: JAGSNPHARM
Last Ten Days Market Price
| Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
|---|
| 22 Nov 2024 | 640.2 | 597.6 | 654.95 | 583.55 |
| 21 Nov 2024 | 591.65 | 575.1 | 603.5 | 565 |
| 19 Nov 2024 | 578.1 | 600.65 | 622 | 570.9 |
| 18 Nov 2024 | 591.7 | 542.4 | 599.95 | 538 |
| 14 Nov 2024 | 533.2 | 579.95 | 579.95 | 527.1 |
| 13 Nov 2024 | 531.9 | 550.25 | 570.15 | 527.5 |
| 12 Nov 2024 | 561.25 | 569 | 599.4 | 548.1 |
| 11 Nov 2024 | 570.15 | 634.95 | 634.95 | 564 |
| 08 Nov 2024 | 590.8 | 601.4 | 602.95 | 579.65 |
| 07 Nov 2024 | 598.75 | 620 | 627 | 590 |
| Date |  Price (₹) |
|---|---|
| 22 Nov 2024 | 640.2 |
| 21 Nov 2024 | 591.65 |
| 19 Nov 2024 | 578.1 |
| 18 Nov 2024 | 591.7 |
| 14 Nov 2024 | 533.2 |
| 13 Nov 2024 | 531.9 |
| 12 Nov 2024 | 561.25 |
| 11 Nov 2024 | 570.15 |
| 08 Nov 2024 | 590.8 |
| 07 Nov 2024 | 598.75 |
×
PRICE
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
Market Price of Jagsonpal Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Jagsonpal Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
FAQs for Board of Directors of Jagsonpal Pharmaceuticals Ltd
How are members of Jagsonpal Pharmaceuticals Ltd Board of Directors selected?
Members of the Jagsonpal Pharmaceuticals Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Jagsonpal Pharmaceuticals Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Jagsonpal Pharmaceuticals Ltd Board of Directors?
Shareholders can interact with the Jagsonpal Pharmaceuticals Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Jagsonpal Pharmaceuticals Ltd Board of Directors meet?
The Jagsonpal Pharmaceuticals Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Jagsonpal Pharmaceuticals Ltd Board of Directors?
The Jagsonpal Pharmaceuticals Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Jagsonpal Pharmaceuticals Ltd?
The current Board of Directors at Jagsonpal Pharmaceuticals Ltd includes Manish Gupta( Managing Director) ,Harsha Raghavan( Chairman & Non Executive Dir.) ,Debasis Bikash Nandy( Independent Director) ,Radhika Dudhat( Independent Director) ,Pallavi Dinodia( Independent Director) . The full list can be found on Jagsonpal Pharmaceuticals Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Unlimited trading at just
Rs. 199*